Monitoring Carboplatin Concentrations in Saliva

L.J.C. van Warmerdam, Jos H. Beijnen(The Netherlands Cancer Institute), Olaf van Tellingen(Dutch Cancer Society), W.W. ten Bokkel Huinink, Sjoerd Rodenhuis(The Netherlands Cancer Institute), R. A. A. Maes(Utrecht University)

Therapeutic Drug Monitoring

October 1, 1995

10.1097/00007691-199510000-00006

Cited by 18

Related Papers

A Gene-Expression Signature as a Predictor of Survival in Breast Cancer

|New England Journal of Medicine|2002|6.5k

Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs

|Cell|1994|2.3k

Overcoming the blood–brain tumor barrier for effective glioblastoma treatment

|Drug Resistance Updates|2015|1k

Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins

|Proceedings of the National Academy of Sciences|1997|941

Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine

|Proceedings of the National Academy of Sciences|1997|884